文献速递神经肿瘤

阐明胶质瘤的分子发病机制:家族性胶质瘤病例系列的胚系与体细胞整合分析

Elucidating the molecular pathogenesis of glioma: integrated germline and somatic profiling of a familial glioma case series.
PubMed 文献 · Neuro Oncol · 2018-01-01

本研究对163例有胶质瘤家族史个体的肿瘤标本进行分子分型,并对其中20例整合胚系与体细胞基因组数据。结果显示家族性胶质瘤的分子特征与散发性胶质瘤高度相似,胚系与体细胞分子事件均靶向胶质瘤发生的共同核心通路。

要点

  • 家族性与散发性胶质瘤的分子图景高度可比。
  • 胚系与体细胞分子事件靶向胶质瘤发生的共同核心通路。
  • 携带胚系胶质瘤风险变异与同一基因的体细胞事件无关。

核心结论

  • 家族性肿瘤的分子特征在很大程度上再现了已知的散发性胶质瘤特征。
  • 胚系和体细胞分子特征均靶向胶质瘤发生中涉及的核心通路。

研究设计与样本

  • 对163例有胶质瘤家族史个体的肿瘤标本进行分子亚型分析,并对其中20例进行胚系与体细胞基因组数据整合分析。
  • 对福尔马林固定石蜡包埋肿瘤切片行免疫组化分析以确定胶质瘤分子亚型。
  • 对20例肿瘤DNA在Illumina HiSeq 2000平台行外显子组测序,并在Illumina HumanOmniExpress BeadChip上行拷贝数分析。
  • 从Illumina Infinium OncoArray胚系DNA确定胶质瘤风险多态性基因型,并从胚系测序数据中鉴定有害胚系突变。

主要发现

  • 整个病例系列涵盖了散发性胶质瘤的全部3种分子亚型,包括分子胶质母细胞瘤(n=102)、少突胶质细胞瘤(n=21)和星形细胞瘤(n=20)。
  • 对其中20例的详细分析显示亚型特异性改变的发生频率与散发性胶质瘤病例相当。
  • 全部20例均存在端粒长度调控基因的改变。
  • 常见胶质瘤风险等位基因的频率与散发性病例相似,且未观察到风险等位基因与同基因体细胞突变之间的相关性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The genomic characterization of sporadically arising gliomas has delineated molecularly and clinically distinct subclasses of disease. However, less is known about the molecular nature of gliomas that are familial in origin. We performed molecular subtyping of 163 tumor specimens from individuals with a family history of glioma and integrated germline and somatic genomic data to characterize the pathogenesis of 20 tumors in additional detail. METHODS: Immunohistochemical analyses were performed on formalin-fixed, paraffin-embedded tumor sections to determine molecular subtypes of glioma. For 20 cases, tumor DNA was exome sequenced on an Illumina HiSeq 2000 platform and copy number profiling was performed on the Illumina HumanOmniExpress BeadChip. Genotypes at glioma risk polymorphisms were determined from germline DNA profiled on the Illumina Infinium OncoArray and deleterious germline mutations were identified from germline sequencing data. RESULTS: All 3 molecular subtypes of sporadic glioma were represented in the overall case series, including molecular glioblastoma (n = 102), oligodendroglioma (n = 21), and astrocytoma (n = 20). Detailed profiling of 20 of these cases showed characteristic subtype-specific alterations at frequencies comparable to sporadic glioma cases. All 20 cases had alterations in genes regulating telomere length. Frequencies of common glioma risk alleles were similar to those among sporadic cases, and correlations between risk alleles and same-gene somatic mutations were not observed. CONCLUSIONS: This study illustrates that the molecular characteristics of familial tumors profiled largely recapitulate what is known about sporadic glioma and that both germline and somatic molecular features target common core pathways involved in gliomagenesis. KEY POINTS: 1. Familial and sporadic gliomas display highly comparable molecular landscapes. 2. Germline and somatic molecular events target common core pathways involved in gliomagenesis. 3. Carriage of germline glioma risk variants is not associated with somatic events in the same gene.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Jacobs DI, Fukumura K, Bainbridge MN, et al. Elucidating the molecular pathogenesis of glioma: integrated germline and somatic profiling of a familial glioma case series. Neuro Oncol. 2018. PMID: 30165405. doi:10.1093/neuonc/noy119

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。